Re: Olaparib Combined with Abiraterone in Patients with Metastatic Castration-Resistant Prostate Cancer: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish (US)
    Pages (from-to)667
    Number of pages1
    JournalJournal of Urology
    Volume201
    Issue number4
    DOIs
    StatePublished - 2019

    ASJC Scopus subject areas

    • Urology

    Cite this